Indications |
Nasal Rhinitis Adult: 140 mcg by nasal spray into each nostril bid. Child: ≥5 yr: 140 mcg by nasal spray into each nostril bid. Ophthalmic Conjunctivitis Adult: Instill 1-2 drops of 0.05% solution into the affected eye/s bid, may increase to four times daily in severe cases. Child: ≥4 yr: Instill 1-2 drops of 0.05% solution into the affected eye/s bid, may increase to four times daily in severe cases. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Pregnancy, lactation. Tip of the bottle should be dipped in boiling water, dried and capped appropriately after every use. |
Adverse Reactions |
Irritation, stinging and itching of the nasal mucosa. Sneezing, nosebleeds, headache; nausea, taste disturbances, somnolence, dry mouth. |
Overdose Reactions |
Accidental oral ingestion of large doses may lead to tremor, convulsions, decreased muscle tone and salivation. General supportive measures should be used. |
Drug Interactions |
Additive effects with CNS depressants and ethanol. See Below for More azelastine Drug Interactions |
Mechanism of Actions |
Azelastine blocks histamine H1-receptor activity and inhibits release of inflammatory mediators from mast cells. Absorption: 40% absorbed sytemically through the nasal mucosa (intranasal). Metabolism: Hepatic. Excretion: Via faeces. |
Storage Conditions |
Nasal: Store at 20-25°C. Ophthalmic: Store at 2-25°C. |
ATC Classification |
R01AC03 - azelastine ; Belongs to the class of topical antiallergic preparations, excluding corticosteroids. Used as antiallergic agents. R06AX19 - azelastine ; Belongs to the class of other antihistamines for systemic use. S01GX07 - azelastine ; Belongs to the class of other ophthalmologic antiallergics. |
Storage |
Nasal: Store at 20-25°C. Ophthalmic: Store at 2-25°C. |
Available As |
|
Azelastine
Post Review about Azelastine Click here to cancel reply.
Azelastine Containing Brands
Azelastine is used in following diseases
Drug - Drug Interactions of Azelastine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.